CHINA SXT PHARMACEUTICALS IN's ticker is and the CUSIP is G2161P132. A total of 5 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 10,540 | $2 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 105,039 | $23 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 20,564 | $4,833 | 0.00% |
| Cetera Advisor Networks LLC | 10,415 | $2,448 | 0.00% |
This page lists CHINA SXT PHARMACEUTICALS IN's shareholders in Q2 2023. To view CHINA SXT PHARMACEUTICALS IN's shareholder history, click here.